TRIM-EDICINE INC

TRIM-edicine is a privately held biotechnology company that translates distinctive protein and peptide biology into therapeutic approaches for tissue repair, regenerative medicine, age-related dysfunction, and oncology. Its historical portfolio spans membrane repair, tissue protection, cellular homeostasis, aging biology, and peptide therapeutics for cancer, with applications explored in dermal wounds, ischemia/reperfusion injury, oral health, sports medicine, and muscular dystrophy. The company's development model combines proof-of-concept research and translational validation with partnerships involving academic, government, and industry collaborators to advance discoveries toward therapeutic products.